ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

COYA vs NTHI // FREE CASH FLOW YIELD

Coya Therapeutics Inc. (NASDAQ) VS. NeOnc Technologies Holdings Inc. (NASDAQ) • 15-METRIC TALLY: COYA 4 — NTHI 1
▲ FREE CASH FLOW YIELD LEADER: COYA
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COYA VS. NTHI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC COYA NTHI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -11.50% -21.93% +10.43 COYA /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 123.60% -51.80% +175.40 COYA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.08 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 COYA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.5 50.6 -23.12 NTHI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $93.4M $92.9M $492.0K COYA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR COYA REV NTHI REV COYA GROSS % NTHI GROSS % COYA FCF NTHI FCF
FY 2025 $7.9M $40.0K — — -$10.7M -$20.4M
FY 2024 $3.6M $83.0K — — -$10.3M -$4.2M
FY 2023 $6.0M — — — -$11.2M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COYA // BETA —
NTHI // BETA —